WS Management’s bluebird bio BLUE Stock Holding History

WS Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-561	Closed	-$71K	–	70
2022 Q3	$71K	Hold	561	–	–	0.01%	72
2022 Q2	$46K	Hold	561	–	–	﹤0.01%	77
2022 Q1	$54K	Hold	561	–	–	﹤0.01%	69
2021 Q4	$112K	Sell	561 -305	-35%	-$72K	0.01%	62
2021 Q3	$214K	Hold	866	–	–	0.02%	70
2021 Q2	$359K	Hold	866	–	–	0.04%	71
2021 Q1	$338K	Sell	866 -44	-5%	-$21.7K	0.04%	62
2020 Q4	$510K	Hold	910	–	–	0.05%	53
2020 Q3	$636K	Hold	910	–	–	0.07%	60
2020 Q2	$719K	Sell	910 -156	-15%	-$118K	0.09%	52
2020 Q1	$635K	Sell	1,066 -54	-5%	-$52.6K	0.07%	58
2019 Q4	$1.27M	Hold	1,120	–	–	0.11%	48
2019 Q3	$1.33M	Sell	1,120 -124	-10%	-$189K	0.1%	52
2019 Q2	$2.05M	Sell	1,244 -147	-11%	-$254K	0.13%	55
2019 Q1	$2.83M	Sell	1,391 -187	-12%	-$329K	0.17%	53
2018 Q4	$2.03M	Sell	1,578 -1,019	-39%	-$1.56M	0.1%	64
2018 Q3	$4.91M	Hold	2,597	–	–	0.16%	60
2018 Q2	$5.28M	Buy	+2,597	New	+$5.92M	0.15%	57

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WS Management's BLUE Position: Q4 2022 in Review

WS Management sold out of bluebird bio (BLUE) in Q4 2022, closing a stake of 561 shares — an estimated $71K sold.

WS Management first reported a position in BLUE in Q2 2018 and held it in 18 quarters. The position peaked at $5.28M in Q2 2018. 184 funds tracked by Wall St. Rank hold BLUE as of Q4 2022.

WS Management reported no remaining bluebird bio position as of Q4 2022 after selling out during the quarter.
WS Management sold 561 bluebird bio shares in Q4 2022, an estimated $71K.
WS Management first reported a position in bluebird bio in Q2 2018 and held it in 18 quarters.
WS Management's bluebird bio position peaked at $5.28M in Q2 2018.
184 funds tracked by Wall St. Rank held bluebird bio as of Q4 2022.

Based on WS Management's 13F filing for Q4 2022, filed 14 Feb 2023.